Significance of second transurethral resection on patient outcomes in muscle-invasive bladder cancer patients treated with bladder-preserving multimodal therapy.

SÜER E., Hamidi N., GÖKCE M. İ., GÜLPINAR Ö., Turkolmez K., Beduk Y., ...Daha Fazla

World journal of urology, cilt.34, sa.6, ss.847-51, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 34 Sayı: 6
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1007/s00345-015-1710-5
  • Dergi Adı: World journal of urology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.847-51
  • Anahtar Kelimeler: Bladder cancer, Bladder preserving, Multimodal therapy, Second resection, COMBINED-MODALITY THERAPY, LONG-TERM OUTCOMES, UROTHELIAL CARCINOMA, PRESERVATION, RADIATION, SURVIVAL
  • Ankara Üniversitesi Adresli: Evet

Özet

Although the role of second transurethral resection of bladder tumor (TURB) is well established in high-risk non-muscle-invasive bladder cancer, to the best of our knowledge, there is no study regarding the role of a second transurethral resection (TUR) after a complete first TURB in multimodal therapy (MMT). The aim of this study was to evaluate the role of a second TUR on disease-specific survival (DSS) and overall survival (OS) rates in muscle-invasive bladder cancer (MIBC) patients who were treated with MMT.